HMS today announced it has acquired VitreosHealth, a privately held company based in Plano, Texas, that offers predictive and prescriptive health insights for population risk models. Prior to the acquisition, VitreosHealth served as a key strategic partner for HMS, and most notably, as the predictive analytics engine for HMS’ Elli, a risk intelligence solution that is part of the company’s integrated Population Health Management (PHM) portfolio.
Elli provides both prospective and retrospective analyses to help identify high and emerging risk as early as the point of member enrollment. Seamlessly integrating with existing population health tools, Elli’s timely, actionable insights on populations and individual members facilitate better care management programs. Elli monitors members on a regular basis to proactively identify risks related to medical conditions, social determinants and other factors.
“We are excited to add VitreosHealth’s talent and advanced analytics expertise to the HMS family,” said Bill Lucia, HMS Chairman and CEO. “Our successful partnership with VitreosHealth has evolved into today’s highly strategic acquisition of best-in-class predictive analytics capabilities. We expect VitreosHealth’s prescriptive health insights will further enrich our award-winning Population Health Management suite to better predict, identify and avoid preventable high-cost events.”
VitreosHealth’s artificial intelligence-driven platform leverages data from a broad set of sources, including electronic health records, claims, health risk assessments and socioeconomic data. It then provides insights that allow clinicians and health plan administrators alike to identify and address care gaps within their member or patient populations.
Also, VitreosHealth’s advanced analytic predictions into the care management workflow offers critical insights that help health plans and managed care organizations optimize their Star and other quality ratings, recognize undercoding/overcoding patterns and analyze out-of-network utilization.
VitreosHealth Co-Founder and CEO, Jay Reddy, said, “We are excited to join forces with HMS, a dynamic healthcare technology and services leader that is like-minded in its focus on improving health outcomes and reducing costs across the healthcare continuum.”
HMS believes the integration of VitreosHealth will enhance our predictive modeling and analytics capabilities within its PHM solution suite and further drive customer value by:
- Enhancing risk stratification capabilities with disease-specific predictive models
- Enabling faster identification of rising risk members
- Improving outcomes through prescriptive interventions
HMS acquired VitreosHealth for approximately $36.5 million, which was funded with cash on hand.
HMS, Elli and the HMS logo are registered trademarks of HMS Holdings Corp. and/or its affiliates. Other names may be trademarks of their respective owners.
SVP, Investor Relations
Sr. Director, External Communications